30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Hughes-Wilson Alexandra

Insider profile

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Hughes-Wilson Alexandra's trades of Mereo BioPharma Group PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-09-16 2024-09-13 S Sale
52,159 +22.8%
216.33
US$82,846
52,159 +22.8% 216.33 US$82,846
2024-09-16 2024-09-13 S Sale
97,786 -8.9%
255.74
US$3,632,857
97,786 -8.9% 255.74 US$3,632,857
2024-09-16 2024-09-12 S Sale
57,239 -34.8%
442.55
US$80,422
57,239 -34.8% 442.55 US$80,422
2024-09-16 2024-09-12 S Sale
7,769 -3.9%
4.47
US$34,748
7,769 -3.9% 4.47 US$34,748
2024-09-12 2024-09-12 PrS Proposed sale
148,110
4.66
US$690,193
148,110 4.66 US$690,193
2024-06-27 2024-06-26 S Sale
22,968 -39.9%
3.39
US$77,935
22,968 -39.9% 3.39 US$77,935
2024-06-27 2024-06-25 S Sale
10,134 -15.0%
3.69
US$37,434
10,134 -15.0% 3.69 US$37,434
2024-06-24 2024-06-25 PrS Proposed sale
33,102
3.98
US$131,746
33,102 3.98 US$131,746
2024-06-20 2024-06-21 PrS Proposed sale
33,102
3.98
US$131,746
33,102 3.98 US$131,746
2024-05-23 2024-05-22 PrS Proposed sale
100,432
2.96
US$297,506
100,432 2.96 US$297,506
2024-05-23 2024-05-22 S Sale
50,082 -60.6%
2.94
US$147,241
50,082 -60.6% 2.94 US$147,241
2024-05-23 2024-05-22 S Sale
50,350 -46.2%
2.99
US$150,546
50,350 -46.2% 2.99 US$150,546
2019-05-22 2019-05-20 B Purchase
1,650
5.42
US$8,943
1,650 5.42 US$8,943